Results 51 to 60 of about 4,078 (132)

Direct estimation of activity concentration in regional voxels with application to 177Lu peptide receptor radionuclide therapy

Medical Physics, Volume 53, Issue 4, April 2026.
Abstract Background Quantitative SPECT in radionuclide‐therapy is limited by partial‐volume effects (PVEs). The implementation of regional voxels (r.v.), estimating mean activity concentrations in regions directly from projections, offers a promising alternative for the geometry‐specification to reduce PVEs.
Johan Gustafsson, Erik Larsson, Katarina Sjögreen Gleisner   +2 more
wiley   +1 more source

Risk of bowel ischemia in patients with mesenteric neuroendocrine tumors after treatment with 177Lu-DOTATATE

Endocrine Oncology
Background: Lutetium-177 (177Lu)-DOTATATE is an effective treatment for metastatic gastroenteropancreatic (GEP) NETs. However, radiation can cause transient inflammation/swelling of tumors, which can result in toxicity.
Eleonora Pelle, Taymeyah Al-Toubah, Ghassan El-Haddad, Brian Morse, Bhavana Konda, Vineeth Sukrithan, Jonathan Strosberg   +6 more
doaj   +1 more source

Enhancing Diagnostic Pathways for Bronchopulmonary Neuroendocrine Tumors: Assessment of the South Wales Neuroendocrine Tumor Service Transformation

Thoracic Cancer, Volume 17, Issue 8, April 2026.
Implementation of a dedicated neuroendocrine cancer service in South Wales significantly shortened diagnostic and treatment timelines for bronchopulmonary NETs, demonstrating the benefits of coordinated specialist input. ABSTRACT Background Bronchopulmonary neuroendocrine tumors (bpNETs) are uncommon lung neoplasms posing significant diagnostic and ...
Arouba Imtiaz, Oliver Burbidge, Mat Jones, Robin Ghosal, Janardhan Navaratnam, Craig Dyer, Helen E. Davies, Mohid S. Khan   +7 more
wiley   +1 more source

Endoscopic Ultrasound for the Management of Pancreatic Neuroendocrine Tumors: Diagnosis, Treatment, and Future Perspectives

Journal of Gastroenterology and Hepatology, Volume 41, Issue 4, Page 1173-1190, April 2026.
ABSTRACT Pancreatic neuroendocrine tumors (PanNETs) are increasingly diagnosed, reflecting greater clinical awareness, improved imaging, and revised classification. This review summarizes evidence on epidemiology, diagnostic workup, and endoscopic ultrasound (EUS)–guided management of PanNETs, encompassing diagnostic evaluation, tissue acquisition, and
Angelo Bruni, David Meacci, Roberto Falbo, Marco Fichera, Francesco Poggioli, Riccardo Casadei, Claudio Ricci, Leonardo Henry Eusebi   +7 more
wiley   +1 more source

The effect of LysaKare infusion on serum potassium levels in patients with gastroenteropancreatic neuroendocrine tumours eligible for treatment with [177Lu]Lu‐DOTA‐TATE: A post‐authorisation safety study

Journal of Neuroendocrinology, Volume 38, Issue 4, April 2026.
Abstract A post‐authorisation safety study (PASS) was conducted to assess the impact of LysaKare (2.5% Lysine‐Arginine solution) on serum potassium concentrations and its safety/tolerability profile in patients with gastroenteropancreatic neuroendocrine tumours (GEP‐NET) eligible for 177Lu‐DOTATATE treatment.
Johannes Hofland, Chiara Maria Grana, Martin O. Weickert, Andrew R. Moore, Tahir Shah, Vineet Prakash, Agnieszka Kolasińska‐Ćwikła, Wouter W. de Herder, Francesca Spada, Lingfei Xu, Ramon Fite, Yuan Wu, Jarosław B. Ćwikła   +12 more
wiley   +1 more source

Salvage PRRT with 177Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival

BMC Cancer, 2019
Background NETTER-1 trial demonstrated high efficacy and low toxicity of four cycles of Peptide Receptor Radionuclide Therapy (PRRT) in patients with metastasized NET.
S. Rudisile, A. Gosewisch, V. Wenter, M. Unterrainer, G. Böning, F. J. Gildehaus, W. P. Fendler, C. J. Auernhammer, C. Spitzweg, P. Bartenstein, A. Todica, H. Ilhan   +11 more
doaj   +1 more source

European Society of Neuroendocrine Tumors (ENETS) 2025 guidance paper for lung and thymic carcinoids

Journal of Neuroendocrinology, Volume 38, Issue 4, April 2026.
Abstract This ENETS guidance paper, developed by a multidisciplinary working group, provides up‐to‐date and practical advice on the diagnosis and management of lung and thymic carcinoids, based on recent developments and study results. These recommendations aim to provide practical recommendations for the diagnosis, treatment and follow‐up of these ...
Eric Baudin, Alice Durand, Wieneke Buikhuisen, Jaume Capdevila, Martyn Caplin, Christophe M. Deroose, Clarisse Dromain, Antongiulio Faggiano, Pier Luigi Filosso, Gregory Kaltsas, Marco Volante, Thomas Walter, Rocio Garcia‐Carbonero   +12 more
wiley   +1 more source

Osteology of the Feeding Apparatus of Chilean Flamingo Phoenicopterus chilensis (Aves: Phoenicopteridae)

Journal of Morphology, Volume 287, Issue 3, March 2026.
1. The skull features a broad, dorsoventrally flattened frontal region articulating with an elongated upper jaw that is complemented by the mandible's downward bend along its proximal half. 2. The low mechanical advantage in the mandible is attributed to the reduced and shallow insertion areas of the adductor muscles, which are positioned close to the ...
Oscar Aldana Ardila, Caio J. Carlos
wiley   +1 more source

Dosimetry methods and clinical applications in peptide receptor radionuclide therapy for neuroendocrine tumours: a literature review

EJNMMI Research, 2018
Background The main challenge for systemic radiation therapy using radiopharmaceuticals (SRT) is to optimise the dose delivered to the tumour, while minimising normal tissue irradiation.
Daphne Merel Valerie Huizing, Berlinda Jantina de Wit-van der Veen, Marcel Verheij, Marcellus Petrus Maria Stokkel   +3 more
doaj   +1 more source

Recommendations for bone‐directed therapy in patients with neuroendocrine tumour skeletal metastases at the New Zealand National Neuroendocrine Tumour Multidisciplinary Meeting

Internal Medicine Journal, Volume 56, Issue 3, Page 465-468, March 2026.
Abstract The role of anti‐resorptive agents in patients with bone metastases from neuroendocrine neoplasms is unclear. Our aim was to review bone‐specific treatment recommendations by the New Zealand National Neuroendocrine Tumour Multidisciplinary Meeting (MDM).
Gayle Radley, Marianne S Elston, Ben Lawrence, Veronica Boyle   +3 more
wiley   +1 more source